InVivium Capital

InVivium Capital

Chicago, Illinoisinvivium.com

Overview

InVivium Capital is a venture capital investment firm based in Chicago, Illinois, that focuses on investments in healthcare and life sciences. Through its seed and venture development programs, the firm provides access and forms lasting relationships from seed through the later stages of growth. They seek transformative solutions that provide a step-change in value to patients, payers, providers, pharma and biotech and invest across the spectrum of innovation in healthcare and life sciences, including biotechnology, medical devices, tools and diagnostics, and healthcare IT. InVivium's investment scope spans the US and can also include opportunistic investments in global and under-ventured geographies.

Portfolio Companies

4

Investments

CompanyDateStageLead
Onchilles PharmaNov 2025Series A ExtensionCo-investor
Grove BiopharmaApr 2025Series ACo-investor
Hinge BioJan 2025Series ACo-investor
Virtual IncisionSep 2023Series C ExtensionLead
Virtual IncisionJun 2023Series CLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersChicago, Illinois
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.